Aurinia Pharmaceuticals (AUPH) Enterprise Value Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.06% |
| Dec 31, 2025 | -11.02% |
| Sep 30, 2025 | -0.88% |
| Jun 30, 2025 | 4.64% |
| Mar 31, 2025 | 2.19% |
| Dec 31, 2024 | -2.28% |
| Sep 30, 2024 | -3.21% |
| Jun 30, 2024 | 5.77% |
| Mar 31, 2024 | 11.51% |
| Dec 31, 2023 | 9.99% |
| Sep 30, 2023 | 10.29% |
| Jun 30, 2023 | 10.47% |
| Mar 31, 2023 | 13.66% |
| Dec 31, 2022 | 16.45% |
| Sep 30, 2022 | -31.51% |
| Jun 30, 2022 | -22.89% |
| Mar 31, 2022 | -20.23% |
| Dec 31, 2021 | -17.01% |
| Sep 30, 2021 | -15.13% |
| Jun 30, 2021 | -37.15% |
| Mar 31, 2021 | -27.02% |
| Dec 31, 2020 | -30.16% |
| Sep 30, 2020 | -84.90% |
| Jun 30, 2020 | -76.75% |
| Mar 31, 2020 | -95.36% |
| Dec 31, 2019 | -143.15% |
| Sep 30, 2019 | -17.09% |
| Jun 30, 2019 | 0.61% |
| Mar 31, 2019 | -6.96% |
| Dec 31, 2018 | 27.44% |
| Sep 30, 2018 | -31.24% |
| Jun 30, 2018 | 26.38% |
| Mar 31, 2018 | 35.07% |
| Dec 31, 2017 | -337.49% |
| Sep 30, 2017 | -469.22% |
| Jun 30, 2017 | -1,382.32% |
| Mar 31, 2017 | -1,819.07% |
| Dec 31, 2016 | -151.69% |
| Sep 30, 2016 | 25.28% |
| Jun 30, 2016 | 62.94% |
| Mar 31, 2016 | 100.00% |